
Sandoz breaks ground on new Slovenia facility to expand European biosimilars
Sandoz has started construction for a new, state-of-the-art biosimilars production center for sterile product manufacturing in Brnik, Slovenia. This $440 million project brings the company’s total planned and ongoing investment in Slovenia to more than $1. …